ArticleClinical rheumatology2025
One-year follow-up of a short specific carbohydrate diet intervention in children with juvenile idiopathic arthritis: A retrospectively controlled study with focus on medical burden.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04205500 (Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis
Who cites it
1 citing paper in PubMed.
- Recent antibiotic exposure and response to treatment of juvenile idiopathic arthritis: a retrospective cohort study.Arthritis research & therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesStudies on diet as a complementary treatment in children with juvenile idiopathic arthritis (JIA) are limited. We have previously reported initial findings from a study exploring the potential anti-inflammatory effects of a 1-month specific carbohydrate diet (SCD) in children with JIA. This paper presents the full-year follow-up results, primarily focusing on changes in medication needs before and after the intervention.
methodsTwenty-eight patients with JIA, with low disease activity, were included. The results of disease activity, physical function, pain, morning stiffness, and inflamed joints from the 1-month intervention, as well as long-term effects, were evaluated. The medical burden during the year before and 1 year after the dietary intervention was compared with three times as many retrospective patients with JIA.
resultsDespite adherence challenges, twenty-one children completed at least 1 month on the diet with a significant improvement in clinical variables that appeared to persist for several months. Sixteen children completed a 1-year follow-up, and the medical burden was compared with that of 48 matched retrospective controls. We observed no significant group-level changes in medication use from the dietary intervention. In six participants, the need for medical escalation was eliminated following the dietary intervention, and this effect was maintained for 1 year.
conclusionThe SCD shows promise in alleviating symptoms in children with JIA, both in the short and long-term. While no significant group-level changes were observed, some participants avoided treatment escalations, suggesting individual benefits. However, larger-scale studies using a less complicated diet are necessary to draw definitive conclusions. Clinical Trials Identifier NCT04205500, 2019/12/17, retrospectively registered. URL: https://register. CLINICALTRIALS: gov . Key Points • The specific carbohydrate diet (SCD) allowed some participants to avoid planned medication escalations, indicating its potential role in managing JIA symptoms. • Most participants faced difficulties with long-term adherence to the restrictive SCD, highlighting the need for more sustainable dietary strategies. • Further studies are needed to identify specific dietary components that drive benefits and to explore underlying mechanisms for effective dietary recommendations in pediatric rheumatology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.